搜索





搜索





BridgeBio Pharma Inc

BBIO

添加自选

66.610USD

-0.700-1.04%

收盘 09-18 16:00（美东）

13.01B总市值

亏损市盈率 TTM

BridgeBio Pharma Inc

66.610

-0.700-1.04%

财务摘要利润表资产负债表现金流量表公司收入财报公司估值风险评估

概览

新闻分析

财务

股票评分

技术分析

预测

持股情况

股息

公司资料

财务摘要利润表资产负债表现金流量表公司收入财报公司估值风险评估

BBIO 利润表

您可以在这里找到BridgeBio Pharma Inc的年度或季度收入报告，以深入了解BridgeBio Pharma Inc的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

营业总收入

120.39%243.68M

66.78%194.51M

2521.18%154.18M

4318.01%120.70M

4999.86%110.56M

-44.76%116.63M

237.08%5.88M

-33.22%2.73M

32.11%2.17M

11461.88%211.12M

-6.68%1.75M

1110.36%4.09M

-97.77%1.64M

7.79%1.83M

-85.49%1.87M

-85.58%338.00K

36.51%73.75M

266.67%1.69M

10462.30%12.89M

-71.16%2.34M

--54.02M

--462.00K

-99.12%122.00K

-69.61%8.13M

----

--13.82M

--26.74M

----

--0.00

----

营业收入

109.51%228.24M

58.63%185.01M

2431.42%148.90M

4161.42%116.42M

4924.95%108.94M

-44.76%116.63M

237.08%5.88M

-33.22%2.73M

32.11%2.17M

11461.88%211.12M

-6.68%1.75M

1110.36%4.09M

-97.77%1.64M

7.79%1.83M

-85.49%1.87M

-85.58%338.00K

36.51%73.75M

266.67%1.69M

10462.30%12.89M

-71.16%2.34M

--54.02M

--462.00K

-99.12%122.00K

-69.61%8.13M

----

--13.82M

--26.74M

----

--0.00

----

主营业务成本

311.88%15.05M

276.62%9.94M

289.01%8.11M

997.49%6.56M

510.87%3.65M

341.30%2.64M

248.49%2.08M

0.00%598.00K

-0.17%598.00K

-8.14%598.00K

-7.57%598.00K

-19.08%598.00K

-14.43%599.00K

-51.71%651.00K

-58.28%647.00K

-49.17%739.00K

542.20%700.00K

--1.35M

--1.55M

--1.45M

--109.00K

----

--0.00

--2.50M

----

--0.00

----

营业费用

43.73%350.75M

36.31%300.47M

24.38%282.61M

35.39%257.06M

39.60%244.04M

6.30%220.44M

27.36%227.22M

17.55%189.86M

21.22%174.82M

66.41%207.38M

44.56%178.41M

29.79%161.51M

-0.90%144.21M

-18.39%124.62M

-30.86%123.41M

-18.05%124.44M

-1.70%145.53M

-9.08%152.71M

39.88%178.50M

18.57%151.84M

18.84%148.04M

63.89%167.97M

38.02%127.61M

57.58%128.07M

79.88%124.57M

65.97%102.49M

40.98%92.46M

96.05%81.27M

99.09%69.25M

47.60%61.75M

--65.58M

--41.46M

--34.78M

--41.84M

研发费用

34.36%149.45M

13.65%126.64M

-10.69%116.42M

-6.29%112.87M

-3.02%111.23M

-20.96%111.43M

0.10%130.35M

-3.75%120.44M

6.70%114.69M

51.81%140.97M

43.26%130.23M

35.27%125.14M

-0.84%107.49M

-13.74%92.86M

-25.61%90.90M

-11.31%92.51M

6.32%108.40M

-12.17%107.65M

35.52%122.20M

13.31%104.31M

17.74%101.96M

79.64%122.56M

56.87%90.17M

66.52%92.05M

65.48%86.60M

59.21%68.22M

12.27%57.48M

77.47%55.28M

119.03%52.33M

26.67%42.85M

--51.20M

--31.15M

--23.89M

--33.83M

折旧摊销及损耗

-20.05%1.05M

-7.63%1.19M

4.97%1.44M

-9.10%1.40M

-16.33%1.32M

-19.55%1.28M

-13.75%1.37M

-6.16%1.54M

-3.85%1.57M

-2.27%1.60M

-4.52%1.58M

-0.36%1.64M

3.48%1.64M

-13.32%1.63M

8.78%1.66M

--1.65M

-60.96%1.58M

--1.88M

--1.53M

----

--4.05M

----

385.71%374.00K

214.29%132.00K

330.77%112.00K

--100.00K

--77.00K

--42.00K

--26.00K

其他营业费用

---15.05M

----

营业利润

19.77%-107.08M

-2.08%-105.96M

41.97%-128.43M

27.13%-136.36M

22.69%-133.47M

-2873.23%-103.80M

-25.29%-221.33M

-18.87%-187.13M

-21.10%-172.65M

103.05%3.74M

-45.35%-176.66M

-26.85%-157.42M

-98.62%-142.57M

18.69%-122.79M

26.61%-121.54M

16.99%-124.10M

23.65%-71.78M

9.84%-151.02M

-29.90%-165.61M

-24.65%-149.50M

24.53%-94.02M

-63.44%-167.50M

-62.12%-127.49M

-119.94%-119.94M

-79.88%-124.57M

-65.97%-102.49M

-19.91%-78.64M

-31.54%-54.53M

-99.09%-69.25M

-47.60%-61.75M

---65.58M

---41.46M

---34.78M

---41.84M

净非营业利息收入（费用）

利息收入

70.83%6.66M

15.99%6.25M

-7.50%4.33M

89.29%6.24M

-24.97%3.90M

32.15%5.38M

-16.05%4.68M

-13.10%3.30M

15.09%5.20M

-1.88%4.08M

36.31%5.58M

56.93%3.79M

489.30%4.51M

1455.43%4.15M

2148.35%4.09M

932.91%2.42M

137.15%766.00K

-32.23%267.00K

-59.38%182.00K

-66.18%234.00K

-65.42%323.00K

-79.70%394.00K

-81.41%448.00K

-74.71%692.00K

-43.80%934.00K

-7.88%1.94M

63.61%2.41M

418.18%2.74M

83000.00%1.66M

210600.00%2.11M

--1.47M

--528.00K

--2.00K

--1.00K

利息费用

45.13%54.62M

25.33%52.81M

68.72%50.31M

108.79%48.15M

64.09%37.64M

79.54%42.14M

47.13%29.82M

13.57%23.06M

11.38%22.94M

16.65%23.47M

1.39%20.27M

2.43%20.31M

1.55%20.59M

-1.10%20.12M

32.09%19.99M

79.14%19.82M

87.09%20.28M

108.91%20.34M

38.06%15.13M

1.26%11.07M

0.79%10.84M

142.84%9.74M

260.59%10.96M

417.23%10.93M

454.04%10.75M

139.98%4.01M

157.85%3.04M

82.79%2.11M

846.83%1.94M

23771.43%1.67M

--1.18M

--1.16M

--205.00K

--7.00K

出售证券收益

----

-100.00%0.00

100.00%0.00

-100.00%0.00

743.98%8.14M

--21.27M

---5.35M

-98.67%1.44M

--964.00K

--0.00

--107.95M

----

股权收益

68.13%-6.43M

-17.53%-18.28M

-25.96%-21.03M

-141.26%-15.83M

-154.75%-20.19M

---15.56M

---16.70M

---6.56M

---7.92M

----

-1618.18%-4.72M

---6.59M

---4.96M

---4.60M

---275.00K

--0.00

特殊收入（费用）

100.00%0.00

-137.18%-11.13M

-118.65%-8.84M

-100.65%-805.00K

27.56%-21.73M

-522.41%-4.69M

17528.68%47.41M

3594.85%123.40M

-790.18%-29.99M

90.20%-754.00K

94.58%-272.00K

57.94%-3.53M

85.13%-3.37M

---7.69M

---5.02M

---8.40M

---22.66M

----

-100.00%0.00

---416.00K

--0.00

---2.00M

--19.33M

--0.00

----

其他非经营性收入（费用）

-14.68%5.59M

-48.33%4.25M

627.71%11.82M

816.03%16.46M

1136.08%6.55M

511.06%8.23M

216.57%1.62M

2582.09%1.80M

-1641.46%-632.00K

186.07%1.35M

-88.75%513.00K

-98.94%67.00K

100.38%41.00K

79.34%-1.56M

-83.88%4.56M

1025.58%6.33M

-540.21%-10.82M

-231.37%-7.58M

849.76%28.28M

-7700.00%-684.00K

234.48%2.46M

1116.46%5.77M

1984.81%2.98M

-96.40%9.00K

-934.25%-1.83M

131.16%474.00K

94.74%-158.00K

4066.67%250.00K

130.59%219.00K

-159.56%-1.52M

---3.00M

--6.00K

---716.00K

---586.00K

税前利润

14.18%-155.89M

1.80%-166.56M

26.85%-194.75M

-13.53%-186.48M

-140.47%-181.66M

-369.05%-169.61M

-56.31%-266.24M

8.49%-164.25M

52.99%-75.54M

74.67%-36.16M

-21.17%-170.33M

-28.03%-179.49M

-6179.91%-160.70M

29.11%-142.73M

7.69%-140.57M

12.93%-140.19M

97.49%-2.56M

-17.68%-201.33M

-12.78%-152.28M

-23.70%-161.02M

25.06%-102.07M

-64.37%-171.08M

-60.46%-135.03M

-114.57%-130.17M

-83.42%-136.21M

-49.90%-104.08M

-70.90%-84.15M

-44.17%-60.66M

-108.01%-74.27M

-63.65%-69.44M

---49.24M

---42.08M

---35.70M

---42.43M

所得税

-100.00%0.00

----

-110.41%-120.00K

---1.54M

--2.10M

--0.00

--1.15M

----

除税后利润

15.17%-155.89M

1.80%-166.56M

27.21%-194.63M

-12.59%-184.94M

-143.25%-183.76M

-369.05%-169.61M

-56.98%-267.39M

8.49%-164.25M

52.99%-75.54M

74.67%-36.16M

-21.17%-170.33M

-28.03%-179.49M

-6179.91%-160.70M

29.11%-142.73M

7.69%-140.57M

12.93%-140.19M

97.49%-2.56M

-17.68%-201.33M

-12.78%-152.28M

-23.70%-161.02M

25.06%-102.07M

-64.37%-171.08M

-60.46%-135.03M

-114.57%-130.17M

-83.42%-136.21M

-49.90%-104.08M

-70.90%-84.15M

-44.17%-60.66M

-108.01%-74.27M

-63.65%-69.44M

---49.24M

---42.08M

---35.70M

---42.43M

持续经营利润

15.17%-155.89M

1.80%-166.56M

27.21%-194.63M

-12.59%-184.94M

-143.25%-183.76M

-369.05%-169.61M

-56.98%-267.39M

8.49%-164.25M

52.99%-75.54M

74.67%-36.16M

-21.17%-170.33M

-28.03%-179.49M

-6179.91%-160.70M

29.11%-142.73M

7.69%-140.57M

12.93%-140.19M

97.49%-2.56M

-17.68%-201.33M

-12.78%-152.28M

-23.70%-161.02M

25.06%-102.07M

-64.37%-171.08M

-60.46%-135.03M

-114.57%-130.17M

-83.42%-136.21M

-49.90%-104.08M

-70.90%-84.15M

-44.17%-60.66M

-108.01%-74.27M

-63.65%-69.44M

---49.24M

---42.08M

---35.70M

---42.43M

归属少数股东的净利润

-98.11%-3.67M

-14.91%-2.51M

24.24%-1.77M

0.90%-2.19M

11.16%-1.85M

-131.57%-2.19M

-7.29%-2.34M

11.05%-2.21M

25.53%-2.09M

63.35%-944.00K

26.82%-2.18M

12.79%-2.49M

-138.43%-2.80M

47.78%-2.58M

41.65%-2.98M

43.83%-2.85M

227.44%7.30M

38.36%-4.93M

66.07%-5.11M

64.49%-5.08M

62.28%-5.73M

34.57%-8.00M

-40.69%-15.04M

-1991.81%-14.31M

-81.36%-15.18M

-48.25%-12.23M

-0.88%-10.69M

93.59%-684.00K

8.53%-8.37M

-364.37%-8.25M

---10.60M

---10.68M

---9.15M

--3.12M

归属于母公司的净利润

16.32%-152.22M

2.02%-164.04M

27.24%-192.86M

-12.78%-182.74M

-147.64%-181.90M

-375.41%-167.42M

-57.63%-265.05M

8.45%-162.04M

53.48%-73.46M

74.87%-35.22M

-22.21%-168.15M

-28.88%-177.00M

-1502.06%-157.90M

28.64%-140.16M

6.51%-137.59M

11.93%-137.34M

89.77%-9.86M

-20.43%-196.40M

-22.67%-147.18M

-34.59%-155.94M

20.40%-96.35M

-77.55%-163.08M

-63.33%-119.98M

-93.16%-115.86M

-83.68%-121.03M

-50.12%-91.85M

-90.10%-73.46M

-91.01%-59.98M

-116.72%-65.89M

-64.14%-61.19M

---38.64M

---31.40M

---30.41M

---37.28M

归属于普通股东的净利润

16.32%-152.22M

2.02%-164.04M

27.24%-192.86M

-12.78%-182.74M

-147.64%-181.90M

-375.41%-167.42M

-57.63%-265.05M

8.45%-162.04M

53.48%-73.46M

74.87%-35.22M

-22.21%-168.15M

-28.88%-177.00M

-1502.06%-157.90M

28.64%-140.16M

6.51%-137.59M

11.93%-137.34M

89.77%-9.86M

-20.43%-196.40M

-22.67%-147.18M

-34.59%-155.94M

20.40%-96.35M

-77.55%-163.08M

-63.33%-119.98M

-93.16%-115.86M

-83.68%-121.03M

-50.12%-91.85M

-90.10%-73.46M

-91.01%-59.98M

-116.72%-65.89M

-64.14%-61.19M

---38.64M

---31.40M

---30.41M

---37.28M

基本每股收益

18.57%-0.78

4.36%-0.84

28.78%-1.00

-10.81%-0.95

-143.83%-0.95

-346.82%-0.88

-45.17%-1.40

20.69%-0.86

60.19%-0.39

78.54%-0.20

-4.61%-0.96

-16.75%-1.08

-1363.88%-0.98

31.80%-0.92

9.06%-0.92

12.68%-0.93

89.77%-0.07

-14.44%-1.35

-0.46%-1.01

-8.44%-1.06

36.53%-0.66

-50.88%-1.18

-61.74%-1.01

-91.37%-0.98

-80.52%-1.03

-46.55%-0.78

-85.54%-0.62

-87.64%-0.51

-116.73%-0.57

-64.13%-0.53

---0.34

---0.27

---0.26

---0.32

稀释每股收益

18.57%-0.78

4.36%-0.84

28.78%-1.00

-10.81%-0.95

-143.83%-0.95

-346.82%-0.88

-45.17%-1.40

20.69%-0.86

60.19%-0.39

78.54%-0.20

-4.61%-0.96

-16.75%-1.08

-1363.88%-0.98

31.80%-0.92

9.06%-0.92

12.68%-0.93

89.77%-0.07

-14.44%-1.35

-0.46%-1.01

-8.44%-1.06

36.53%-0.66

-50.88%-1.18

-61.74%-1.01

-91.37%-0.98

-80.52%-1.03

-46.55%-0.78

-85.54%-0.62

-87.64%-0.51

-116.73%-0.57

-64.13%-0.53

---0.34

---0.27

---0.26

---0.32

每股派息

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 BridgeBio Pharma Inc 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 BBIO 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

BridgeBio Pharma Inc 财年末的营收是多少？



BridgeBio Pharma Inc 2025 财年营收为 502.08M，高于上一财年的221.90M。

BridgeBio Pharma Inc 最近一个季度的营收是多少？



BridgeBio Pharma Inc 最近一个季度的营收为 243.68M，同比增长 120.39%。

BridgeBio Pharma Inc 全年的净利润是多少？



BridgeBio Pharma Inc 2025 财年净利润为 -724.93M。

BridgeBio Pharma Inc 上一季度的净利润是多少？



BridgeBio Pharma Inc 最近一个季度的净利润为 -152.22M。

BridgeBio Pharma Inc 年度营业利润是多少？



BridgeBio Pharma Inc 2025 财年的营业利润为 -502.06M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。